Purchases and Sales Made in Q3 2022 in Sorrento Therapeutics, Inc. (SRNE)
This table provides information about the institutional ownership of Sorrento Therapeutics, Inc. (SRNE) during Q3 2022. The information is specifically focused on institutions that hold shares of Sorrento Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-824K- 14.02% |
$1.24M - $2.37M
|
5.06M
$1.67M
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-900K- 79.33% |
$1.36M - $2.59M
|
235K
$77.4K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.87M- 63.02% |
$2.83M - $5.39M
|
1.1M
$363K
|